George Millen: Unscripted

Derek Taylor's move from CN to G&W is more than a hire; it's a strategic play by private equity to supercharge operations and redefine the short-line sector.

Sub-Zero's new ice maker isn't just about clear cubes. It's a masterclass in market leadership, tackling consumer pain points to secure its 20-year legacy.

One year in, global broker ATFX expands in Phnom Penh, backed by regulators. The move signals a major shift for Cambodia's maturing financial markets.

New research reveals why employees bypass corporate travel tools: they can't find what they need. This 'invisible spend' is costing firms millions.

While ComEd’s massive storm response is a logistical victory, it serves as a stark preview of the multi-billion-dollar price tag for grid resilience.

E! co-founder Larry Namer says Hollywood is a standard, not a place. But when a Chinese state media arm promotes his vision, is it cultural bridging or soft power?

BusRight's award for a Texas driver does more than honor one man; it exposes the deep cracks in America's student transit system and one firm's plan to fix them.

As Dead by Daylight celebrates 10 years, we look past the sold-out fan fest to the strategy that turned a Montreal studio into a global economic force.

Binance re-enters the tokenized stock arena with bStocks, offering 24/7 access to US equities. But what do the regulatory approvals and fine print mean?

Cousins Maine Lobster's Texas road trip is more than a culinary event. It's a masterclass in market penetration and franchise growth from a Shark Tank legend.

WyreStorm unveils its Synergy Control Flow, betting on open-source logic and AI to slash AV integration time. Can this challenge the proprietary giants?

The maker of Crisco and Cream of Wheat extends its debt maturity to 2031, but at a staggering 11% rate, revealing the harsh realities of today's credit markets.

Canada's new Digital Safety Act could ban social media for kids under 16 and create a new regulator. What does this mean for Big Tech's bottom line?

Exavalu's new ExAite platform uses 'agentic AI' to automate software testing, promising huge cost savings and faster releases for the insurance sector.

FloBiotech and UCLA Health are betting on a new strategy against neurodegeneration: boosting the brain's own defenses. This alliance could redefine a field long plagued by failure.

CRRC Zhuzhou Institute leverages a Bulgarian success story and top-tier safety validation to launch a new high-density energy storage system for Europe.

Homeowners are tapping equity at the highest Q1 rate since 2021, not by refinancing, but through a surge in second liens not seen in two decades.

Amai Proteins' sweelin® just got a major scientific boost. New clinical data in a top journal proves its metabolic safety, fast-tracking its commercial journey.

Guelph's new bus chargers are more than infrastructure; they represent a new era of predictable federal funding reshaping municipal finance and strategy.

A French firm is using a special economic zone to bypass China's tough regulations. Is its scarless vein treatment a medical breakthrough or a brilliant market hack?